Exploring the structural similarity yet functional distinction between coagulation factor XIII-B and complement...

Area of Science:

• Biochemistry
• Immunology
• Molecular Biology

Background:

• Coagulation factor XIII (FXIII) crosslinks fibrin clots, preventing premature breakdown.
• FXIII comprises catalytic FXIII-A and regulatory FXIII-B subunits.
• FXIII-B shares homology with complement regulator Complement factor H (CFH), suggesting a potential role in complement activation.

Purpose of the Study:

• To investigate the potential role of FXIII-B in complement activation.
• To compare FXIII-B with CFH using in silico analysis.
• To evaluate the functional impact of FXIII-B on complement activation in vitro and in cell lines.

Main Methods:

• In silico sequence alignment and structural analysis of FXIII-B and CFH.
• Reconstitution experiments of FXIII components in FXIII-deficient and CFH-deficient plasma.
• Transient expression of FXIII-B in SH-SY5Y cell lines to assess complement activation.

Main Results:

• In silico analysis revealed similarities and functional divergence between FXIII-B and CFH.
• Complement activation assays showed no significant effect of FXIII-B reconstitution or expression.
• FXIII-B did not alter the rate of complement activation in deficient plasma or cell lines.

Conclusions:

• FXIII-B subunit does not play a role in the physiological complement system.
• While structurally similar to CFH, FXIII-B lacks a direct function in complement regulation.
• A vestigial role for FXIII-B in complement activation in specific pathological states cannot be entirely excluded.